
Here's how to solve the looming shortage of doctors: Nurse practitioners (USA Today)
Features Duke University
Op-Ed: Think you want to die at home? You might want to think twice about that (LA Times)
Features Nathan Gray, MD
Rush Limbaugh and Shannen Doherty have advanced cancer. What does that mean? What is stage IV? (USA Today)
Features James Abbruzzese, MD
Side effect of long commutes: Car seat carcinogens (CBS News)
Features Duke University
One In Four Cancer Survivors Can’t Afford Their Medical Care–And We’re Blaming The Wrong People
Features Peter Ubel, MD
Oral Oncology Parity Laws Don’t Make Medications More Affordable (Cancer Therapy Advisor)
Yousuf Zafar, MD, MHS
Secord Shares Data to Digest With PARP Inhibitors in Ovarian Cancer (OncLive)
Features Angeles Alvarez Secord, MD
CRM1 Emerges as a Potential Target in Osteosarcoma in Novel Drug Discovery Model (OncLive)
Features Alexander Leandros Lazarides, MD
WATCH: Dr. Eward on the Unmet Need for Novel Agents for TGCT and Sarcoma (OncLive)
Features William Eward, DVM, MD
Symptoms, Diagnosis, and QoL in Patients With Myelofibrosis (OncLive)
Features Harry Erba, MD, PhD
Education, Collaboration Key to Increasing Genetic Screening in Prostate Cancer (OncLive)
Features Thomas J. Polascik, MD
WATCH: Dr. Armstrong on the Rationale of the PROPHECY Trial in mCRPC (OncLive)
Features Andrew Armstrong, MD
Pasireotide Does Not Decrease Risk of GI Toxicity or Acute GVHD Following HSCT (OncLive)
Features Anthony Sung, MD
'How Long Do I Have?' New Online Tool for Patients With Cancer (Medscape)
Features Thomas LeBlanc, MD
First-Line Cyramza in NSCLC Gets Split Decision From FDA Panel (Medscape)
Features Susan Halabi, PhD
How a modified poliovirus may help fight brain cancer (Medical News Today)
Features Matthias Gromeier, MD
Preoperative breast radiotherapy: a tool to provide individualized and biologically-based radiation therapy (Gateway for Cancer Research)
Features Rachel Blitzblau, MD, PhD
WATCH: Rebecca Previs, MD, Speaks on Uterine Cancer Research & Treatment (Kay Yow Cancer Fund)
Celebrate Duke's Presidential Award Winners (Duke Today)
Features Duke Health Development colleagues
What's in North Carolina Drinking Water? (Duke Today)
Features Heather Stapleton, PhD
Yuan Receives DOD Prostate Cancer Research Program Early Investigator Award (Duke Pathology)
Fuwen Yuan, PhD
Amanda Hargrove Has a Target on Hard-to-Fight Diseases (Duke: Trinity College of Arts & Sciences)
Features Amanda Hargrove, PhD
"Cervical Cancer Revolution” Proposal Among Top 100 for MacArthur $100 Million Grant (Pratt School of Engineering)
Features Nimmi Ramanujam, PhD
In Detecting Prostate Cancer, Which Biopsy Procedure is Best? (Duke Health)
Features Thomas Polascik, MD
Papers
Androgen receptor variant-driven prostate cancer II: advances in clinical investigation. Nature. Feb. 24. Landon C. Brown, Changxue Lu, Emmanuel S. Antonarakis, Jun Luo & Andrew J. Armstrong.
Anti–PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. Science Translational Medicine. Feb. 19. Zilong Wang, Changyu Jiang, Qianru He, Megumi Matsuda, Qingjian Han, Kaiyuan Wang, Sangsu Bang, Huiping Ding, Mei-Chuan Ko, and Ru-Rong Ji.
Pan-cancer analysis of whole genomes. Nature. Feb. 5, 2020. *Hundreds of contributors, including, from Duke: Darell Bigner, MD, PhD, Jeffrey Marks, PhD, and research teams at Duke-NUS.
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study. Neuro-Oncology. 17 December 2019. Andrew J Brenner, Katherine B Peters, James Vredenburgh, Felix Bokstein, Deborah T Blumenthal, Shlomit Yust-Katz, Idit Peretz, Bernice Oberman, Laurence S Freedman, Benjamin M Ellingson, Timothy F Cloughesy, Naamit Sher, Yael C Cohen, Noa Lowenton-Spier, Tamar Rachmilewitz Minei, Niva Yakov, Itzhak Mendel, Eyal Breitbart, Patrick Y Wen.
A multidisciplinary consensus recommendation on a synoptic radiation treatment summary: A Commission on Cancer Workgroup report. Practical Radiation Oncology. Jan. 24, 2020. John Christodouleas, MD, MPH, Nate Anderson, MS, Peter Gabriel, MD, MSE, Rick Greene, MD, Carol Hahn, MD, Susanne Kessler, MS, Chuck Mayo, PhD, Todd McNutt, PhD, Lawrence N. Shulman, MD, Ben Smith, MD, MPH, Jeff West, BA, Ted Williamson, MD, PhD, CTR.
GU ASCO 2020

Combo Impresses in Advanced Bladder Cancer (MedPage Today) Features Brant Inman, MD
Clinical Trials in Genitourinary Cancers: Investigating New Treatments for Kidney, Bladder, and Prostate Cancers (ASCO)
Features Neeraj Agarwal, MD and Tian Zhang, MD




